Replies to post #2016 on Ocera Therapeutics fka OCRX

[longx]

Very nice, BR
Hope that you've purchased a bunch of shares in the .60s

[puravida]

potentially good news. they halt/unhalt the stock then make everyone wait till 11:20am for details at Cowen. Should be a wild session up to then

[DewDiligence]

Slide set (for Cowen webcast today), including new data reported in today’s PR:

http://ir.ocerainc.com/common/download/download.cfm?companyid=ABEA-5YQ58G&fileid=931914&filekey=4AB0E968-A6F7-4459-86F5-1FABAD7B4F5F&filename=Ocera_Therapeutics_Presents_at_Investor_Conference_March_2017.pdf

[Sage7243]

I am no scientist, but these stats look good to me. This co. should trade at $4 on speculation alone.

[DewDiligence]

OCRX presents additional post-hoc data from STOP-HE trial—reports 1Q17 results:

http://ir.ocerainc.com/releasedetail.cfm?releaseid=1025649

I think OCRX has a fair—but not great—chance of persuading the FDA to endorse advancing OCR-002 to phase-3, using the kind of trial design proposed on today's CC.